ArticleFrontiers in physiology2026
Interpretable multi-center machine learning model driven by facial image features for non-invasive early risk assessment of lung cancer.
Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early identification of lung cancer is critical for improving patient survival and prognosis. Conventional pathological biopsy is invasive, and computed tomography (CT) involves ionizing radiation risks. Facial imaging, as a non-invasive and accessible biological signal, is a promising novel approach for lung cancer auxiliary diagnosis. Objective: To develop and validate a non-invasive lung cancer auxiliary diagnosis model based on facial image features, and explore the value of facial imaging in lung cancer early screening. Methods: Multi-center patients with benign pulmonary nodules and lung cancer were enrolled in this study. Facial images were collected via the TFDA-1 Digital Tongue and Face Diagnosis Instrument, with 124 features extracted. Logistic regression was used for feature selection and simple correlation analysis of facial image features, based on which four machine learning models (XGBoost, LightGBM, SVM, GBDT) were constructed. Model training and optimization were performed using 10-fold cross-validation combined with grid search for hyperparameter tuning. Model performance was comprehensively evaluated using Accuracy, Precision, Sensitivity, Specificity, F1-Score, area under the curve (AUC), average precision (AP), and Brier Score; pairwise comparisons of AUCs among models were conducted using the DeLong test. Clinical utility was assessed using calibration curves and decision curves; model interpretability was analyzed via the SHapley Additive exPlanations (SHAP) method; and generalization capability was validated using an independent external validation cohort. Results: The XGBoost model achieved the best overall performance, with an AUC of 0.900 and accuracy of 0.807 in the internal test set, and an AUC of 0.906 and accuracy of 0.813 in the external validation set, demonstrating favorable generalization stability. DeLong test showed that XGBoost achieved the highest AUC in the internal test set without significant differences among models (all Conclusion: We successfully constructed a non-invasive auxiliary screening model for lung cancer using facial image features. Facial imaging shows significant value in early lung cancer screening, providing a novel, accessible strategy to improve the popularization and availability of lung cancer early screening in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.